Srs Capital Advisors, Inc. Amphastar Pharmaceuticals, Inc. Transaction History
Srs Capital Advisors, Inc.
- $1.95 Billion
- Q2 2025
A detailed history of Srs Capital Advisors, Inc. transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 81 shares of AMPH stock, worth $2,166. This represents 0.0% of its overall portfolio holdings.
Number of Shares
81Holding current value
$2,166% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AMPH
# of Institutions
257Shares Held
33.3MCall Options Held
18.3KPut Options Held
12.6K-
Black Rock Inc. New York, NY5.94MShares$159 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.69MShares$71.9 Million0.0% of portfolio
-
Td Asset Management Inc2.03MShares$54.4 Million0.04% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.63MShares$43.5 Million0.01% of portfolio
-
State Street Corp Boston, MA1.58MShares$42.2 Million0.0% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.31B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...